for the Period Ended 30 June 2025
| Balance sheet | |
| Notes |
As at
|
Notes |
2025 |
2024 |
|
|---|---|---|---|
|
|
£ |
£ |
|
| Called up share capital not paid: |
|
||
| Fixed assets | |||
| Intangible assets: |
|
|
|
| Investments: | 3 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Stocks: |
|
||
| Debtors: |
|
|
|
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: |
( |
( |
|
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Total net assets (liabilities): |
|
|
|
| Capital and reserves | |||
| Called up share capital: |
|
|
|
| Share premium account: |
|
|
|
| Profit and loss account: |
|
||
| Shareholders funds: |
|
|
The notes form part of these financial statements
The directors have chosen to not file a copy of the company’s profit & loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 June 2025
for the Period Ended 30 June 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 30 June 2025
Investments in subsidiary undertakings are held at cost less any provision for impairment. The company's subsidiary undertaking is Aesthetic Holdings Limited, incorporated in England and Wales, in which the company holds 100% of the ordinary shares. Its principal activity is that of a holding company.